PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsCommentClass action lawsuit: has Monash IVF breached its legal duty of care?

BioNews

Class action lawsuit: has Monash IVF breached its legal duty of care?

Published 1 February 2021 posted in Comment and appears in BioNews 1081

Author

Dr Patrick Foong

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

A law firm has filed a class action against Monash IVF, one of Australia's largest IVF clinics, following allegations that the fertility clinic may have destroyed healthy embryos through a defective non-invasive genetic screening test...

A law firm has filed a class action against Monash IVF, one of Australia's largest IVF clinics, following allegations that the fertility clinic may have destroyed healthy embryos through a defective non-invasive genetic screening test (PGT-A test). It has been alleged that the defendants' testing performed on embryos may have resulted in embryos being incorrectly classified as abnormal, ie, generating false-positive results. The IVF patients and some of their partners sued for tens of millions of dollars in financial compensation, with many concerned they may have been stripped of their chance of bearing children. 

In the class action, the lead plaintiff, Danielle Bopping who is in her 40s, was informed by Monash IVF that her last embryo, which had been categorised as abnormal, may have been viable (see BioNews 1079). They claim that the fertility clinic may have incorrectly labelled healthy embryos as abnormal before disposing of them through a now-suspended non-invasive genetic testing programme. 

Legal documents were filed in the Supreme Court of the state of Victoria, Australia against Monash IVF on behalf of patients who had embryos genetically tested with the IVF clinic between May 2019 and October 2020. The allegation is that Monash IVF has breached its legal duty of care owed to their patients by failing to inform them that genetic testing could return a false-positive. Such an omission could amount to misleading behaviour. As lead plaintiff, Bopping will provide instructions to the law firm regarding the case's conduct and may give evidence during the legal proceeding.

Genetic screening allows the detection of gene mutations that could be inherited by the next generation, determining the offspring's risk of being born with severe or deadly genetic conditions. The lawsuit emerges amid revelations that the innovative genetic testing used by Monash IVF is less reliable than initially thought. 

More than 1000 Monash IVF patients could be victims. This could be one of the most significant class actions ever lodged against a fertility provider in Australia, and comprises plaintiffs from various states including Victoria, New South Wales, the Australian Capital Territory, Northern Territory, Tasmania, Queensland and South Australia. Members of the class action seek compensation for financial losses as well as pain and suffering, with some worried they may have lost their chance to have offspring. For the patients, the news has only added to the stress of a long and tedious fertility process. 

The class action comes after a 2018 independent review into Victoria's regulatory framework of assisted reproductive services (Gorton review), led by Michael Gorton AM. The review explored whether there are sufficient safeguards to protect patients resorting to assisted reproductive treatment. Among the inquiry's findings, there were various incidents, including a doctor who allegedly transferred an unviable embryo into a patient. In another incident, defective incubators in a fertility treatment provider's laboratory resulted in the loss of several embryos. The affected patients were not informed of the equipment failure but were led to believe that the embryos succumbed naturally.

A class action is a crucial part of the legal system in which disputes and claims involving vast numbers of claimants to be determined in just one case, allowing ordinary people to hold huge organisations responsible for misconduct. Class actions provide an avenue to people who otherwise would be denied justice and compensation. 

In Australia, where at least seven plaintiffs have claims that arise out of comparable events, a class action lawsuit can be brought by one claimant on their own behalf as well as a representative of the other group members (Bopping). The requirement of at least seven plaintiffs is a lower threshold compared to other jurisdictions. A huge advantage of a class action is that it saves time and expense. It avoids the need for the judge to determine common issues of fact or law more than once, enabling the recovery of losses reasonably and efficiently and at less individual cost. 

While individuals often lack the resources to tackle a mammoth organisation, when enough IVF patients have suffered a similar grievance, together, they can become formidable. Indeed, class actions are a force for accountability as well as corporate and social responsibility. This class action may set a precedent for other jurisdictions especially for common law nations. 

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
15 January 2021 • 1 minute read

Lawsuit against Monash IVF over embryo testing method

by Anna Wernick

Hundreds of people across Australia are suing the major IVF clinic, Monash IVF, over the destruction of potentially viable embryos...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
11 December 2020 • 2 minutes read

Acoustic waves used to select high-quality sperm in IVF

by Christina Burke

A new approach which uses sound waves to filter sperm for IVF has been developed by Australian researchers...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
13 June 2016 • 3 minutes read

Australian documentary accuses IVF clinics of peddling false hope

by Dr Mary Yarwood

An Australian documentary has claimed that women over 40 are being misled about their chances of conceiving via IVF treatment when using their own eggs...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Will a COVID-19 vaccine change my DNA?

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

FILM: 200 Years of Mendel – From Peas to Personalised Medicine

1 August 2022 • 4 minutes read

Women's Health Strategy plans reflect rising needs of same-sex female couples

25 July 2022 • 4 minutes read

Was the Women's Health Strategy worth the wait?

25 July 2022 • 4 minutes read

Why the UK should extend the 14-day rule to 28 days

25 July 2022 • 5 minutes read

200 Years of Mendel: From Peas to Personalised Medicine

8 August 2022 • 4 minutes read

Citizenship and same-sex parents – about time, Sweden!

8 August 2022 • 2 minutes read

FILM: 200 Years of Mendel – From Peas to Personalised Medicine

1 August 2022 • 4 minutes read

Women's Health Strategy plans reflect rising needs of same-sex female couples

25 July 2022 • 4 minutes read

Was the Women's Health Strategy worth the wait?

25 July 2022 • 4 minutes read

Why the UK should extend the 14-day rule to 28 days

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856